Introduction

The objective of tissue engineering is to create or recreate living body parts or organs that will fully integrate with the recipient's body. The advent of tissue engineering as a new field of research with a high potential towards the clinical care of patients from bench to bedside has involved numerous different scientists in various fields of cellular and molecular medicine, material research, engineering, physics, chemistry, computational research
and allied disciplines [1] [2] [3] [4] [5] [3] with direct or indirect relation to the care of human beings seem to be straight forward and do not offer a sufficient potential for ethical debates [6] [7] [8] . [7] . While questions of intellectual property have been widely published in this context, there is limited literature on ethics in cellular and molecular medicine and for the field of tissue engineering [6, 9, 10] .
. Due to a potentially enormous impact on the health of our society -that is as a whole continuously becoming older -tissue-engineered solutions to circumvent natural degenerative processes have become of great interest. They may aid to maintain a high quality of life in the elderly. This issue has been widely acknowledged, but has created numerous debates also. Many of the techniques applied in research and in practical applications of nowadays tissue engineering approaches
Nevertheless, innovative medical research and new technologies always raise ethical and policy concerns. In biomedical research, these issues include the ethical conduct of basic and clinical research as well as the equitable distribution of new therapies
With respect to the ethics of tissue engineering, Derksen and Horstman [11] ' and 'lived integrity' [11] . Nevertheless, due to the translational character of cellular and molecular medicine [16] [17] [18] [19] [29, 30] . [4, [31] [32] [33] [34] [24] , researchers have successfully begun to assay human embryonic stem cell function using prenatal chimeras [37] . As [22, 23] .
Historical aspects
While research with stem cells from the very beginning has evoked many controversial debates worldwide not only within the recent years (especially when those cells are derived from embryos), there is comparatively little public debate on ethical issues in cellular and molecular research, when it is not directly correlated to clinical applications. A survey of the literature reveals that the term 'ethics' in cellular and molecular medicine is not covered in a database such as
Ethical aspects of mixing human and animal tissues
Many experiments in various fields of research in cellular and molecular medicine are performed worldwide on a daily routine without a thorough discussion of ethical implications. In tissue engineering, it is common practice to seed human cells on biomaterials. Cultured or non-cultured human cells are frequently seeded onto experimental animals
According to Karpowicz et al. [22] [22] . [43, 44, 46] . Suggestions [48, 49] . [21] .
The mixing of genes, human and animal cells or tissues from humans with those of animals has been studied for many years. In reality, techniques involving human-animal combinations have been used in the laboratories for decades. For instance, the utilization of animal cells (irradiated mouse fibroblasts) as carriers for the culture of human keratinocytes has been common practice for decades by now. The transplantation of cultured human keratinocytes propagated on animal cell feeder layers has also been published to be life saving in extensively burned patients [41-46]. Serum-free culture techniques and utilization of biomaterials have been introduced to circumvent animal influences on cultured human cells
Gene therapy in cell science and tissue engineering
It is quite obvious that the potential market for gene-specific pharmaceuticals is huge. Hence, research in cellular and molecular medicine involving alteration of the genome is one of the cornerstones of scientific progress. Ethically, the idea of gene therapy is to introduce or to alter genetic material to compensate for a genetic mistake that causes disease. By doing so, it is hoped that one day by means of gene therapy diseases can be treated or cured for which up to now no other effective treatments are available. However, many unique technical and ethical considerations have been raised by this comparatively new form of treatment [47]. Consecutively several levels of regulatory committees have been established to review each gene therapy clinical trial prior to its initiation in human subjects. Ethical considerations include the decision which diseases and/or traits
